Related Experiment Video
Updated: Jun 8, 2025

10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
427
Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body
Rebecca A Abelman1,2, Yifei Ma1, C Christina Mehta3
1Department of Medicine, University of California, San Francisco, California, USA.
Summary
Switching to integrase strand transfer inhibitors (INSTIs) during menopause accelerates waist circumference increases in women with HIV. Healthcare providers should consider menopausal status when prescribing INSTIs to manage body composition changes.
Area of Science:
- HIV/AIDS research
- Endocrinology
- Pharmacology
Background:
- Integrase strand transfer inhibitors (INSTIs) and menopause are linked to body composition changes in women with HIV (WWH).
- The interaction between INSTI use and menopausal transition regarding body composition in WWH is not well understood.
Purpose of the Study:
- To investigate the impact of switching to INSTI-based regimens on body composition changes during the menopausal transition in women with HIV.
- To compare body composition changes between women with HIV on INSTIs versus those not on INSTIs, and women without HIV.
Main Methods:
- 1131 virally-suppressed women with HIV (WWH) and 887 women without HIV (WWOH) were analyzed from 2006-2019.
- Mixed-effects models assessed changes in waist circumference (WC) and BMI across menopausal phases (premenopause, late perimenopause, menopause).
- Menopausal phase was determined using anti-Müllerian hormone levels.
Main Results:
- During premenopause, WC increases were similar across all groups.
- In late perimenopause, women switching to INSTIs (INSTI+) showed significantly faster WC increases compared to women not switching (INSTI-) and WWOH.
- In menopause, INSTI+ users experienced accelerated WC increases, peaking around 41-43 months, while INSTI- users had smaller increases.
Conclusions:
- Switching to INSTI-based regimens during late perimenopause and menopause is associated with increased waist circumference in women with HIV.
- Menopausal status is a critical factor to consider when initiating INSTI therapy in women with HIV to monitor and manage body composition.
- Further research into managing weight gain and body composition changes in WWH undergoing menopausal transition is warranted.
Related Concept Videos
Sexually Transmitted Infections
283
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
283
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Menopause
140
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
140

